Search Results for "Ejaculation Clinical Video"

22:19 EST 25th November 2015 | BioPortfolio

Matching Channels

Video capsule endoscopy


PolyXen® is an enabling technology for protein drug delivery.  It uses the natural polymer polysialic acid (PSA) to prolong the active life and improve the stability of therapeutic peptides...


ImuXen® is a liposomal technology platform designed to improve the delivery and effectiveness of DNA, protein and polysaccharide vaccines. Proof of concept preclinical studies with a number of...

Matching News

Advances in understanding and treating premature ejaculation

Our understanding of the epidemiology, pathophysiology, and management of premature ejaculation has increased substantially in recent years. Expert-agreed definitions of premat...

Premature ejaculation isn't a true illness

A new review argues that premature ejaculation—which has become the center of a multimillion dollar business—should not be classified as a male sexual dysfunction. By pointing to false assumptions...

Clinical Trial Spotlight: Should a Second Generation ALK Inhibitor be First Line Therapy for Patients with ALK-Positive NSCLC?

Dr. Jack West asks the question of whether newer, more active ALK inhibitors such as alectinib should be used as first line therapy rather than for acquired resistance, including introducing the ALEX ...

Clinical Trial Spotlight: Can Epigenetic Priming Improve Efficacy of Immunotherapy in NSCLC?

Dr. Jack West reviews the concept of epigenetics, epigenetic priming, and whether oral azacytidine can improve outcomes in patients who receive immunotherapy for advanced lung cancer.Related Posts:Cli...

Clinical Trial Spotlight: Should a Third Generation EGFR Inhibitor be First Line Therapy for EGFR Mutation-Positive NSCLC?

Dr. Jack West introduces the question of whether third generation

Clinical Trial Spotlight: Options for EGFR Mutation-Positive Patients with T790M Mutation-Negative Acquired Resistance

Dr. Jack West reviews treatment options for patients with an

Testosterone fails to help with ejaculation problems

(Reuters Health) - In a four-month trial, testosterone therapy did not improve ejaculation problems in men with low testosterone levels.

Clinical Trials of Immune Checkpoint Inhibitors as First Line Therapy for Advanced NSCLC

Dr. Jack West summarizes the rationale for testing immune checkpoint inhibitors as a first line treatment for patients with advanced

Matching PubMed Articles

Association Between Changes in Serum 5-Hydroxy-Tryptamine Concentrations and Improvement in Clinical Symptoms in Primary Premature Ejaculation with Paroxetine Treatment.

BACKGROUND This study aimed to investigate the association between changes in serum 5-hydroxy tryptamine (5-HT) concentrations and improvement in clinical symptoms in primary premature ejaculation wit...

Management of male neurologic patients with infertility.

Many aspects of fertility rely on intact neurologic function and thus neurologic diseases can result in infertility. While research into general female fertility and alterations in male semen quality ...

Pharmacotherapy for premature ejaculation.

Four premature ejaculation (PE) subtypes are distinguished on the basis of the duration of the intravaginal ejaculation latency time (IELT), its course in life, and frequency of complaints. Since the ...

Evaluation of Simulated Clinical Breast Exam Motion Patterns Using Marker-Less Video Tracking.

This study investigates using marker-less video tracking to evaluate hands-on clinical skills during simulated clinical breast examinations (CBEs).

The characterization, current medications, and promising therapeutics targets for premature ejaculation.

Premature ejaculation (PE) is the most prevalent male sexual dysfunction. This is associated with negative personal and interpersonal psychological outcomes. The pharmacologic treatment of PE includes...

Search Whole site using Google


Advertisement Advertisement